DROXIA 6335 DROXIA 6335 (Droxia 200 mg)

Generic Name: hydroxyurea

Pill imprint DROXIA 6335 DROXIA 6335 has been identified as Droxia 200 mg.

Droxia is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for DROXIA 6335 DROXIA 6335

Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia 200 mg DROXIA 6335 DROXIA 6335
Droxia
Generic Name:
hydroxyurea
Imprint:
DROXIA 6335
DROXIA 6335
Strength:
200 mg
Color:
Green
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-6335
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)